Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythromycin for APC Nonsense Mutations in Pediatric FAP
NCT02354560Phase 4Unknown
- Start
- Jun 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of erythromycin in familial adenomatous polyposis (FAP). Status: unknown.
02
Drugs
erythromycin
03
Conditions
familial adenomatous polyposis (FAP)
Beyond the preview
Go deeper on NCT02354560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02354560.